Skip to main content

Table 1 Participants’ general clinical characteristics by study group

From: Outcomes of prophylactic lauromacrogol injection versus non-injection in patients with endogenous cesarean scar pregnancy treated by hysteroscopic surgery: a retrospective cohort study

Parameters

Non-L group (n = 53)

L group (n = 78)

P value

Age (years)

34.64 ± 4.82

34.13 ± 5.05

0.562

Gestational age (days)

46.26 ± 6.99

45.01 ± 9.07

0.399

Fetal heartbeat positive, n (%)

21 (39.6)

26 (33.3)

0.461

Gravidity (n)

4.0 (3.0, 5.0)

4.0 (3.0, 5.0)

0.160

Abortion (n)

2.0 (1.0, 3.0)

2.0 (1.0, 3.0)

0.677

Number of cesarean deliveries

  

0.144

 1, n (%)

23 (43.4)

44 (56.4)

 

 ≥ 2, n (%)

30 (56.6)

34 (43.6)

 

 Time from cesarean delivery (years)

5.0 (3.0, 9.0)

5.0 (2.0, 8.0)

0.285

Type of CSP, n (%)

  

0.651

 Type 1

36 (67.9)

50 (64.1)

 

 Type 2

17 (32.1)

28 (35.9)

 

Preoperative serum hCG level (IU/L)

19850.0 (7366.0, 48560.0)

26790.0 (10170.0, 55730.0)

0.137

Uterine scar thickness (cm)

0.35 ± 0.16

0.32 ± 0.12

0.121

Mass size (cm)

2.05 ± 0.92

2.39 ± 1.31

0.109

  1. Data are presented as mean ± standard deviation, median (25th, 75th percentile), or n (%). Values of P < 0.05 were considered statistically significant